BR9814367A - Formas de dosagens de ribavirina sólida administrável oralmente e processo para produzì-las - Google Patents

Formas de dosagens de ribavirina sólida administrável oralmente e processo para produzì-las

Info

Publication number
BR9814367A
BR9814367A BR9814367-0A BR9814367A BR9814367A BR 9814367 A BR9814367 A BR 9814367A BR 9814367 A BR9814367 A BR 9814367A BR 9814367 A BR9814367 A BR 9814367A
Authority
BR
Brazil
Prior art keywords
dosage forms
producing
ribavirin
orally administrable
administrable solid
Prior art date
Application number
BR9814367-0A
Other languages
English (en)
Inventor
Stephen M Liebowitz
Elliot I Stupak
Imtiaz A Chaudry
Winston A Vadino
Frank E Bowen
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9814367(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/997,172 external-priority patent/US5914128A/en
Priority claimed from US08/997,169 external-priority patent/US5916594A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9814367A publication Critical patent/BR9814367A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"FORMAS DE DOSAGENS DE RIBAVIRINA SóLIDA ADMINISTRáVEL ORALMENTE E PROCESSO PARA PRODUZì-LAS"<D>. Uma forma de dosagem sólida administrável oralmente contendo uma composição de ribavirina compactada tendo uma densidade tampão vantajosamente alta de pelo menos 0,6 g/mL tanto como taxas de desintegração e de dissolução surpreendentemente rápidas e onde a ribavirina está substancialmente livre de formas polimórficas de ribavirina e um processo para produzir tais formas de dosagens sólidas é descrito.
BR9814367-0A 1997-12-22 1998-12-21 Formas de dosagens de ribavirina sólida administrável oralmente e processo para produzì-las BR9814367A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/997,172 US5914128A (en) 1997-12-22 1997-12-22 Orally administrable solid dosage form
US08/997,169 US5916594A (en) 1997-12-22 1997-12-22 Process of making solid ribavirin dosage forms
PCT/US1998/026222 WO1999032128A1 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Publications (1)

Publication Number Publication Date
BR9814367A true BR9814367A (pt) 2000-10-17

Family

ID=27130673

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814367-0A BR9814367A (pt) 1997-12-22 1998-12-21 Formas de dosagens de ribavirina sólida administrável oralmente e processo para produzì-las

Country Status (26)

Country Link
US (3) US6337090B1 (pt)
EP (2) EP1321147A1 (pt)
JP (2) JP2001526234A (pt)
KR (1) KR100575389B1 (pt)
CN (1) CN1155388C (pt)
AR (1) AR008977A1 (pt)
AT (1) ATE234103T1 (pt)
AU (1) AU762826B2 (pt)
BR (1) BR9814367A (pt)
CA (4) CA2300452C (pt)
CO (1) CO4970774A1 (pt)
DE (1) DE69812094T2 (pt)
DK (1) DK0991415T3 (pt)
ES (1) ES2191987T3 (pt)
HU (1) HUP0100433A3 (pt)
IL (1) IL136549A (pt)
MY (1) MY119656A (pt)
NO (1) NO20003234L (pt)
NZ (1) NZ504994A (pt)
PE (1) PE20000066A1 (pt)
PL (1) PL190267B1 (pt)
PT (1) PT991415E (pt)
SK (1) SK284520B6 (pt)
TW (1) TW575436B (pt)
WO (1) WO1999032128A1 (pt)
ZA (1) ZA9811726B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100433A3 (en) * 1997-12-22 2003-01-28 Schering Corp Orally administrable solid ribavirin dosage forms and process for producing them
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
EP1263341B1 (en) * 2000-03-06 2008-06-11 Salient Surgical Technologies, Inc. Fluid delivery system and controller for electrosurgical devices
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
KR20030020137A (ko) * 2001-09-03 2003-03-08 진양제약주식회사 리바비린 건조시럽제
AU2002350082B9 (en) * 2001-11-02 2006-08-31 Sandoz Inc. Process for preparing quick dissolving, high loading ribavirin compositions
DE10227148A1 (de) * 2002-06-18 2004-01-08 Biopartners Gmbh Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
WO2004084796A2 (en) * 2003-03-28 2004-10-07 Pharmasset Ltd. Compounds for the treatment of flaviviridae infections
WO2006027125A1 (en) * 2004-09-09 2006-03-16 Bayer Healthcare Ag Pharmaceutical composition in the form of a water soluble solid dosage form
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
CN101243130B (zh) * 2005-08-05 2011-12-07 3M创新有限公司 显示具有改善的流动性的组合物
JP2010510171A (ja) * 2006-08-21 2010-04-02 ユナイテッド セラピューティクス コーポレーション ウイルス感染症の治療のための併用療法
EP2296628B1 (en) * 2008-05-22 2014-05-14 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
WO2009158300A1 (en) * 2008-06-26 2009-12-30 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
WO2010002613A2 (en) * 2008-07-02 2010-01-07 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
US10363453B2 (en) 2011-02-07 2019-07-30 New Balance Athletics, Inc. Systems and methods for monitoring athletic and physiological performance
CA2752008A1 (en) 2011-09-13 2013-03-13 Universite De Montreal Combination therapy using ribavirin as elf4e inhibitor
CN106389363A (zh) * 2016-10-18 2017-02-15 广东肇庆星湖生物科技股份有限公司 一种利巴韦林口服固体制剂及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
DE2735600A1 (de) * 1977-08-06 1979-02-15 Dynamit Nobel Ag Verfahren zur herstellung von phthalid
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63216820A (ja) * 1987-03-05 1988-09-09 Chugai Pharmaceut Co Ltd 抗ウイルス剤
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
JP2908844B2 (ja) * 1990-06-29 1999-06-21 ヤマサ醤油株式会社 抗ウイルス剤
ATE178335T1 (de) * 1992-01-06 1999-04-15 Wellcome Found Therapeutische nukleoside der 2',3'-dideoxy-3'- fluor -purin reihe
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
JPH06298665A (ja) * 1993-04-14 1994-10-25 Toray Ind Inc 抗ウイルス剤
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5492692A (en) * 1993-08-17 1996-02-20 University Of Kentucky Research Foundation Coated products with potent anti-HIV and antimicrobial properties
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2135669A1 (en) * 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
HUP0100433A3 (en) * 1997-12-22 2003-01-28 Schering Corp Orally administrable solid ribavirin dosage forms and process for producing them
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form

Also Published As

Publication number Publication date
TW575436B (en) 2004-02-11
IL136549A0 (en) 2001-06-14
IL136549A (en) 2005-05-17
SK284520B6 (sk) 2005-05-05
SK8942000A3 (en) 2001-04-09
US6335032B1 (en) 2002-01-01
MY119656A (en) 2005-06-30
US6337090B1 (en) 2002-01-08
CA2287056A1 (en) 1999-07-01
CA2300452A1 (en) 1999-07-01
PE20000066A1 (es) 2000-02-09
CA2287056C (en) 2000-08-15
CA2365412C (en) 2002-09-17
CO4970774A1 (es) 2000-11-07
AU2199199A (en) 1999-07-12
JP2006083189A (ja) 2006-03-30
AR008977A1 (es) 2000-03-08
NZ504994A (en) 2002-10-25
DE69812094D1 (de) 2003-04-17
EP0991415A1 (en) 2000-04-12
KR100575389B1 (ko) 2006-05-03
ZA9811726B (en) 1999-06-21
KR20010033441A (ko) 2001-04-25
CN1283117A (zh) 2001-02-07
NO20003234L (no) 2000-08-21
CA2300452C (en) 2000-11-28
HUP0100433A2 (hu) 2001-12-28
ES2191987T3 (es) 2003-09-16
DK0991415T3 (da) 2003-06-16
HK1034674A1 (en) 2001-11-02
JP2001526234A (ja) 2001-12-18
PL341230A1 (en) 2001-03-26
CN1155388C (zh) 2004-06-30
PT991415E (pt) 2003-06-30
CA2323849C (en) 2002-06-11
ATE234103T1 (de) 2003-03-15
EP0991415B1 (en) 2003-03-12
US6051252A (en) 2000-04-18
EP1321147A1 (en) 2003-06-25
AU762826B2 (en) 2003-07-03
DE69812094T2 (de) 2003-12-24
CA2365412A1 (en) 1999-07-01
WO1999032128A1 (en) 1999-07-01
CA2323849A1 (en) 1999-07-01
NO20003234D0 (no) 2000-06-21
HUP0100433A3 (en) 2003-01-28
PL190267B1 (pl) 2005-11-30

Similar Documents

Publication Publication Date Title
BR0013823A (pt) Formas de apresentação farmacêuticas de tramadol e seu processo de fabricação
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
SE9504661D0 (sv) New compounds
BR9915285A (pt) Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
ES2191987T3 (es) Formas de dosificacion de ribavirina solidas, administrables oralmente, y procedimiento de fabricacion.
CY1108093T1 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
BR9612291A (pt) Forma de dosagem sólida bioadesiva
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
ZA200108126B (en) Pharmaceutical compounds.
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
EA200100298A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5
ATE261982T1 (de) Salze von di(uridine 5&#39;-tetraphosphate), verfahren zur herstellung und verwendungen davon
DE60207877D1 (de) Mischung enthaltend procyanidine zur verminderung des appetits bei säugetieren
KR870003974A (ko) 비시클로 치환된 페닐아세토니트릴 유도체
ATE334993T1 (de) Hydratformen des natriumsalzes von alendronat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten
BR9713215A (pt) Formulação de partìcula revestida
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
AU4385399A (en) Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
DE69804865D1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
IT8947756A0 (it) Forme di somministrazione solide, che si decompongono rapidamente, relativo procedimento di produzione e loro impiego
CO5580744A2 (es) Forma de dosificacion oral de un profarmaco de sulfonamida
IL93989A0 (en) Pharmaceutical compositions comprising heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/7056, A61K 9/48

Ipc: A61K 31/7056 (2008.01), A61K 9/48 (2008.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DE ACORDO COM ART. 8O DA LPI.